Stockscreener 앱 받기
72.17
2.47%
-1.83
전일 마감가:
$74.00
열려 있는:
$73.73
하루 거래량:
1.03M
Relative Volume:
1.24
시가총액:
$3.38B
수익:
$1.35B
순이익/손실:
$163.34M
주가수익비율:
22.03
EPS:
3.2763
순현금흐름:
$189.17M
1주 성능:
-12.02%
1개월 성능:
-11.02%
6개월 성능:
-3.01%
1년 성능:
-1.85%
1일 변동 폭
$71.61
$74.39
1주일 범위
$71.61
$83.39
52주 변동 폭
$47.31
$87.32
Haemonetics Corp Stock (HAE) Company Profile
명칭
Haemonetics Corp
전화
(781) 848-7100
주소
125 SUMMER STREET, BOSTON, MA
HAE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
72.17 | 3.46B | 1.35B | 163.34M | 189.17M | 3.2763 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 다운그레이드 | Needham | Buy → Hold |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | 재확인 | Barrington Research | Outperform |
| 2025-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-06-26 | 개시 | Robert W. Baird | Outperform |
| 2025-02-07 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 개시 | JP Morgan | Overweight |
| 2024-11-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 개시 | CL King | Buy |
| 2024-09-11 | 개시 | BofA Securities | Neutral |
| 2024-09-10 | 개시 | BTIG Research | Buy |
| 2024-06-12 | 업그레이드 | Needham | Hold → Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-01-27 | 다운그레이드 | Needham | Buy → Hold |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-08-17 | 재개 | Raymond James | Outperform |
| 2021-06-17 | 개시 | Citigroup | Buy |
| 2021-05-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 개시 | Needham | Buy |
| 2019-08-07 | 재확인 | Barrington Research | Outperform |
| 2019-05-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 재확인 | Barrington Research | Outperform |
| 2018-08-09 | 재확인 | Barrington Research | Outperform |
| 2018-02-07 | 재확인 | Barrington Research | Outperform |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 재확인 | Barrington Research | Outperform |
| 2017-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 재확인 | The Benchmark Company | Hold |
| 2016-09-20 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-08-02 | 재확인 | Jefferies | Buy |
| 2016-08-02 | 재확인 | The Benchmark Company | Hold |
모두보기
Haemonetics Corp 주식(HAE)의 최신 뉴스
BofA Securities Maintains Haemonetics(HAE.US) With Hold Rating, Maintains Target Price $90 - 富途牛牛
Is Haemonetics (HAE) Offering An Opportunity After Recent Share Price Weakness - Yahoo Finance
Haemonetics (NYSE:HAE) Shares Gap DownHere's What Happened - MarketBeat
Will Haemonetics (HAE) beat estimates again in its next earnings report? - MSN
Orchestra BioMed to pick up $21M through Haemonetics’ acquisition of Vivasure - MassDevice
Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $93 - 富途牛牛
Haemonetics (NYSE:HAE) Stock Price Down 6.2%Here's What Happened - MarketBeat
Haemonetics Corp (HAE) Trading Down 3.8% on Jan 13 - GuruFocus
A Look At Haemonetics (HAE) Valuation After Recent Share Price Strength And Margin Expansion Targets - simplywall.st
Haemonetics price target raised to $93 from $90 at Barrington - Yahoo Finance
Haemonetics Corporation (HAE) Stock Analysis: Exploring a 10.95% Upside in the Healthcare Sector - DirectorsTalk Interviews
Haemonetics Acquires Vivasure—Could This Be Its Next Growth Engine? - Smartkarma
Galway’s Vivasure Medical acquired by Haemonetics in €185m deal - Silicon Republic
Haemonetics (HAE) Acquisition of Vivasure Boosts Orchestra BioMed's Finances - GuruFocus
EQT To Sell Stake In Irish Biz To Haemonetics In €185M Deal - Law360
Here's Why Haemonetics (HAE) is a Strong Growth Stock - Yahoo Finance
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - The Manila Times
HAE: Barrington Research Raises Price Target, Maintains Outperfo - GuruFocus
Where Haemonetics Stands With Analysts - Benzinga
San Gabriel Valley Tribune - FinancialContent
Barrington Research Forecasts Strong Price Appreciation for Haemonetics (NYSE:HAE) Stock - MarketBeat
Ireland: Haemonetics Corporation acquires Vivasure Medical for up to €185m - Investors in Healthcare
Haemonetics acquires Ireland-based Vivasure - Medical Device Network
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics - Yahoo Finance
EQT Life Sciences Sells Vivasure Medical to Haemonetics - marketscreener.com
How Recent Moves Are Rewriting The Haemonetics (HAE) Story On Guidance And Valuation - Yahoo Finance
Haemonetics: Re-Rating Complete, Time To Cash In (NYSE:HAE) - Seeking Alpha
A Look At Haemonetics (HAE) Valuation After Recent Share Price Momentum - Yahoo Finance
Haemonetics (NYSE:HAE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Haemonetics completes €185M Vivasure acquisition - BioWorld MedTech
Haemonetics to acquire Vivasure Medical - MedTech Dive
Haemonetics acquires Vivasure Medical for EUR 100M - TipRanks
Irish medtech Vivasure sold in €185m deal to US-listed Haemonetics - Business Post
Haemonetics (NYSE:HAE) Given Buy Rating at BTIG Research - MarketBeat
BTIG Reiterates Buy Rating for Haemonetics (HAE) at $88 Price Ta - GuruFocus
Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition - Benzinga
Irish maker of dissolving vessel-closure implant sold in €185M deal - Stock Titan
Haemonetics (HAE) Acquires Vivasure Medical for €100M - GuruFocus
Haemonetics acquires Vivasure to expand structural heart portfolio - TipRanks
Haemonetics Acquires Vivasure Medical - Nasdaq
Haemonetics Corp Acquires Vivasure Medical Limited - TradingView — Track All Markets
Haemonetics Acquires Vivasure Medical Limited - PR Newswire
Why Haemonetics Corporation stock is considered a top pick2025 Trading Recap & Fast Entry High Yield Tips - Улправда
What risks investors should watch in Haemonetics Corporation stockTreasury Yields & Comprehensive Market Scan Reports - Улправда
Why Haemonetics Corporation (HAZ) stock remains stableJuly 2025 Big Picture & Daily Profit Focused Screening - ulpravda.ru
Needham Downgrades Haemonetics(HAE.US) to Hold Rating - 富途牛牛
Plasmapheresis Machines Market Outlook 2025: Expanding - openPR.com
Haemonetics sets Feb. 5 date to share its third‑quarter results - Stock Titan
Baird Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $99 - 富途牛牛
Is Haemonetics (NYSE:HAE) Using Too Much Debt? - 富途牛牛
Haemonetics Corporation (HAE) Stock Analysis: Insights into a Promising Medical Device Leader with a 9.85% Upside - DirectorsTalk Interviews
Haemonetics Corp (HAE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):